232 related articles for article (PubMed ID: 28981388)
1. Where Are the Opportunities for Reducing Health Care Spending Within Alternative Payment Models?
Rocque GB; Williams CP; Kenzik KM; Jackson BE; Halilova KI; Sullivan MM; Rocconi RP; Azuero A; Kvale EA; Huh WK; Partridge EE; Pisu M
J Oncol Pract; 2018 Jun; 14(6):e375-e383. PubMed ID: 28981388
[TBL] [Abstract][Full Text] [Related]
2. Share of Oncology Versus Nononcology Spending in Episodes Defined by the Centers for Medicare & Medicaid Services Oncology Care Model.
Baumgardner JR; Shahabi A; Linthicum MT; Zacker C; Lakdawalla DN
J Oncol Pract; 2018 Nov; 14(11):e699-e710. PubMed ID: 30423271
[TBL] [Abstract][Full Text] [Related]
3. Association of Participation in the Oncology Care Model With Medicare Payments, Utilization, Care Delivery, and Quality Outcomes.
Keating NL; Jhatakia S; Brooks GA; Tripp AS; Cintina I; Landrum MB; Zheng Q; Christian TJ; Glass R; Hsu VD; Kummet CM; Woodman S; Simon C; Hassol A;
JAMA; 2021 Nov; 326(18):1829-1839. PubMed ID: 34751709
[TBL] [Abstract][Full Text] [Related]
4. Greater Spending Associated with Improved Survival for Some Cancers in OCM-Defined Episodes.
Baumgardner J; Shahabi A; Linthicum M; Vine S; Zacker C; Lakdawalla D
J Manag Care Spec Pharm; 2018 Jun; 24(6):504-513. PubMed ID: 29799330
[TBL] [Abstract][Full Text] [Related]
5. Modeling Episode-Based Payments for Cancer Using Commercial Claims Data.
Polson M; Lord T; Evangelatos T; Kangethe A; Speicher LC; Barrientos S; Zacker C
J Manag Care Spec Pharm; 2019 Feb; 25(2):235-245. PubMed ID: 30698092
[TBL] [Abstract][Full Text] [Related]
6. Health care resource utilization, quality metrics, and costs of bladder cancer within the Oncology Care Model.
Wirtz HS; Hepp Z; Grewal S; Wright P; Fuldeore R; Tomicki S; Hirsch J; Dieguez G; Blakely LJ
Am J Manag Care; 2023 May; 29(5):e136-e142. PubMed ID: 37229787
[TBL] [Abstract][Full Text] [Related]
7. Understanding the Costs Associated With Surgical Care Delivery in the Medicare Population.
Kaye DR; Luckenbaugh AN; Oerline M; Hollenbeck BK; Herrel LA; Dimick JB; Hollingsworth JM
Ann Surg; 2020 Jan; 271(1):23-28. PubMed ID: 30601252
[TBL] [Abstract][Full Text] [Related]
8. The Oncology Care Model: Perspectives From the Centers for Medicare & Medicaid Services and Participating Oncology Practices in Academia and the Community.
Kline R; Adelson K; Kirshner JJ; Strawbridge LM; Devita M; Sinanis N; Conway PH; Basch E
Am Soc Clin Oncol Educ Book; 2017; 37():460-466. PubMed ID: 28561660
[TBL] [Abstract][Full Text] [Related]
9. Cost variation and savings opportunities in the Oncology Care Model.
Baumgardner J; Shahabi A; Zacker C; Lakdawalla D
Am J Manag Care; 2018 Dec; 24(12):618-623. PubMed ID: 30586495
[TBL] [Abstract][Full Text] [Related]
10. National Health Care Spending In 2018: Growth Driven By Accelerations In Medicare And Private Insurance Spending.
Hartman M; Martin AB; Benson J; Catlin A;
Health Aff (Millwood); 2020 Jan; 39(1):8-17. PubMed ID: 31804875
[TBL] [Abstract][Full Text] [Related]
11. Better Patient Care At High-Quality Hospitals May Save Medicare Money And Bolster Episode-Based Payment Models.
Tsai TC; Greaves F; Zheng J; Orav EJ; Zinner MJ; Jha AK
Health Aff (Millwood); 2016 Sep; 35(9):1681-9. PubMed ID: 27605651
[TBL] [Abstract][Full Text] [Related]
12. Multiple Myeloma Cost of Care Under the Oncology Care Model: The Influence of High-Cost Therapies.
Theroux H; Williams A; Liu M; Dahl A; Dreyer T; Horvath K; Isola L
JCO Oncol Pract; 2020 Oct; 16(10):e1078-e1084. PubMed ID: 32459566
[TBL] [Abstract][Full Text] [Related]
13. Assessing Medicare's Approach To Covering New Drugs In Bundled Payments For Oncology.
Muldoon LD; Pelizzari PM; Lang KA; Vandigo J; Pyenson BS
Health Aff (Millwood); 2018 May; 37(5):743-750. PubMed ID: 29733731
[TBL] [Abstract][Full Text] [Related]
14. Contribution of preventable acute care spending to total spending for high-cost Medicare patients.
Joynt KE; Gawande AA; Orav EJ; Jha AK
JAMA; 2013 Jun; 309(24):2572-8. PubMed ID: 23797716
[TBL] [Abstract][Full Text] [Related]
15. Association of Financial Integration Between Physicians and Hospitals With Commercial Health Care Prices.
Neprash HT; Chernew ME; Hicks AL; Gibson T; McWilliams JM
JAMA Intern Med; 2015 Dec; 175(12):1932-9. PubMed ID: 26501217
[TBL] [Abstract][Full Text] [Related]
16. Mandatory Medicare Bundled Payment Program for Lower Extremity Joint Replacement and Discharge to Institutional Postacute Care: Interim Analysis of the First Year of a 5-Year Randomized Trial.
Finkelstein A; Ji Y; Mahoney N; Skinner J
JAMA; 2018 Sep; 320(9):892-900. PubMed ID: 30193277
[TBL] [Abstract][Full Text] [Related]
17. Early Findings From the Oncology Care Model Evaluation.
Brooks GA; Jhatakia S; Tripp A; Landrum MB; Christian TJ; Newes-Adeyi G; Cafardi S; Hassol A; Simon C; Keating NL
J Oncol Pract; 2019 Oct; 15(10):e888-e896. PubMed ID: 31393807
[TBL] [Abstract][Full Text] [Related]
18. Design Challenges of an Episode-Based Payment Model in Oncology: The Centers for Medicare & Medicaid Services Oncology Care Model.
Kline RM; Muldoon LD; Schumacher HK; Strawbridge LM; York AW; Mortimer LK; Falb AF; Cox KJ; Bazell C; Lukens EW; Kapp MC; Rajkumar R; Bassano A; Conway PH
J Oncol Pract; 2017 Jul; 13(7):e632-e645. PubMed ID: 28535101
[TBL] [Abstract][Full Text] [Related]
19. Use and spending on antineoplastic therapy for Medicare beneficiaries with cancer.
Davidoff AJ; Shaffer T; Erten MZ; Shoemaker JS; Zuckerman IH; Pandya N; Stuart BC; Bryant-Comstock LG; Shenolikar R
Med Care; 2013 Apr; 51(4):351-60. PubMed ID: 23222498
[TBL] [Abstract][Full Text] [Related]
20. Simulated Costs of the ASCO Patient-Centered Oncology Payment Model in Medicare Beneficiaries With Newly Diagnosed Advanced Ovarian Cancer.
Moss HA; Havrilesky LJ; Wang FF; Georgieva MV; Hendrix LH; Dinan MA
J Oncol Pract; 2019 Dec; 15(12):e1018-e1027. PubMed ID: 31613721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
